Literature DB >> 34584385

Functions of Monocytes and Macrophages and the Associated Effective Molecules and Mechanisms at the Early Stage of Atherosclerosis.

Liyuan Jin1, Zihui Deng2, Yongyi Bai1, Ping Ye1.   

Abstract

OBJECTIVE: This study aimed to explore the functions and possible underlying regulatory molecules and mechanisms of monocytes and macrophages under early atherosclerotic conditions.
METHODS: THP-1-derived monocytes or macrophages were induced by 50 μg/ml oxidized low density lipoprotein (ox-LDL) for 24 hours, and the degree of lipid metabolism and inflammation were determined. In addition, we identified differentially expressed genes, noncoding ribonucleic acids (RNAs), pathways and mechanisms by RNA sequencing, and performed further correlation analysis and molecular expression verification.
RESULTS: Monocytes could not form foam cells with oil red O staining directly and had low levels of lipids as determined by total cholesterol and triglycerides assays, cholesterol uptake molecules CD36, the class A macrophage scavenger receptor and lectin-like oxidized low-density lipoprotein receptor-1 and cholesterol efflux molecules ATP binding cassette transporter A1, ATP binding cassette transporter G1 and liver X receptor α, and inflammatory factors, which were markedly different from those in macrophages. Additionally, sequencing data showed obviously differentially expressed genes, microRNAs and long noncoding RNAs in the atherosclerotic group. We identified 15 upregulated and downregulated genes, and 10 biological processes and pathways involved in atherosclerosis. Specifically, fatty acid desaturase 2 and apolipoprotein A1 in the peroxisome proliferator-activated receptor signaling pathway were differentially expressed in stimulated macrophages, whereas no changes were observed in the monocyte groups. Furthermore, correlation analysis showed differential expressed lncRNAs targeting miRNAs and mRNAs, and 24 competing endogenous RNA (ceRNA) networks of long noncoding RNA-microRNA-messenger RNA in early oxidative macrophages.
CONCLUSIONS: Monocytes did not directly participate in lipid metabolism before differentiation into macrophages at the early stage in vitro. Furthermore, noncoding RNAs and ceRNA networks might play important roles in regulating the lipid metabolism of macrophages at the early stage of atherosclerosis.

Entities:  

Keywords:  Atherosclerosis; Competing endogenous RNA; Lipid metabolism; Macrophage; Monocyte; Noncoding RNA

Year:  2021        PMID: 34584385      PMCID: PMC8414060          DOI: 10.6515/ACS.202109_37(5).20210323C

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  23 in total

Review 1.  Macrophages in atherosclerosis: a dynamic balance.

Authors:  Kathryn J Moore; Frederick J Sheedy; Edward A Fisher
Journal:  Nat Rev Immunol       Date:  2013-09-02       Impact factor: 53.106

Review 2.  MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases.

Authors:  Rujuan Dai; S Ansar Ahmed
Journal:  Transl Res       Date:  2011-02-01       Impact factor: 7.012

Review 3.  Macrophage Trafficking, Inflammatory Resolution, and Genomics in Atherosclerosis: JACC Macrophage in CVD Series (Part 2).

Authors:  Kathryn J Moore; Simon Koplev; Edward A Fisher; Ira Tabas; Johan L M Björkegren; Amanda C Doran; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2018-10-30       Impact factor: 24.094

Review 4.  Long non-coding RNAs in coronary atherosclerosis.

Authors:  Yiran Wang; Xianjing Song; Zhibo Li; Bin Liu
Journal:  Life Sci       Date:  2018-09-05       Impact factor: 5.037

Review 5.  Long noncoding RNAs and atherosclerosis.

Authors:  Tian Zhou; Jia-wang Ding; Xin-an Wang; Xia-xia Zheng
Journal:  Atherosclerosis       Date:  2016-02-23       Impact factor: 5.162

Review 6.  MicroRNA Regulation of Atherosclerosis.

Authors:  Mark W Feinberg; Kathryn J Moore
Journal:  Circ Res       Date:  2016-02-19       Impact factor: 17.367

Review 7.  Regulation of macrophage immunometabolism in atherosclerosis.

Authors:  Graeme J Koelwyn; Emma M Corr; Ebru Erbay; Kathryn J Moore
Journal:  Nat Immunol       Date:  2018-05-18       Impact factor: 25.606

Review 8.  Atherosclerosis and inflammation: overview and updates.

Authors:  Glaucylara Reis Geovanini; Peter Libby
Journal:  Clin Sci (Lond)       Date:  2018-06-21       Impact factor: 6.124

Review 9.  Monocytes, Macrophages, and Metabolic Disease in Atherosclerosis.

Authors:  Michelle C Flynn; Gerard Pernes; Man Kit Sam Lee; Prabhakara R Nagareddy; Andrew J Murphy
Journal:  Front Pharmacol       Date:  2019-06-13       Impact factor: 5.810

View more
  3 in total

1.  Concomitant elevated serum levels of tenascin, MMP-9 and YKL-40, suggest ongoing remodeling of the heart up to 3 months after cardiac surgery after normalization of the revascularization markers.

Authors:  Da Liu; Danyal Ghani; Justin Wain; Wilson Y Szeto; Krzysztof Laudanski
Journal:  Eur J Med Res       Date:  2022-10-21       Impact factor: 4.981

2.  CircRNA_0050486 promotes cell apoptosis and inflammation by targeting miR-1270 in atherosclerosis.

Authors:  Kai Wang; Xiaolong Bai; Lili Mei; Yanping Miao; Feng Jin
Journal:  Ann Transl Med       Date:  2022-08

3.  Identification of Monocyte-Associated Genes Related to the Instability of Atherosclerosis Plaque.

Authors:  Wentao Qin; Fu Gan; Riguan Liang; Jing Li; Xiaomei Lai; Yongfa Dai; Jie Liu
Journal:  Oxid Med Cell Longev       Date:  2022-09-21       Impact factor: 7.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.